Yadav Ajay Kumar^1,2*, Gnawali Suman² and Yuan Gangbiao¹

¹Department of Nuclear Medicine, The Second Affiliated Hospital of Chongqing Medical University, China
²Department of Radio-Diagnosis, Imaging and Nuclear Medicine, BP Koirala Memorial Cancer Hospital, Bharatpur, Chitwan, Nepal

*Corresponding Author: Yadav Ajay Kumar, Department of Nuclear Medicine, The Second Affiliated Hospital of Chongqing Medical University, China.

Received: August 27, 2021; Published: September 18, 2021

Abstract

  Nanoscale devices are 100 to 10 thousand-fold smaller than human cells. They’re similar in size to massive biological molecules ("biomolecules") like enzymes and receptors. As AN example, hemoglobin, the molecule that carries atomic number 8 in red blood cells, is close to five nanometers in diameter. Nanoscale devices smaller than fifty nanometers will simply enter most cells, whereas those smaller than twenty nanometers will move out of blood vessels as they flow into through the body. Attributable to their tiny size, nanoparticles will promptly perform with biomolecules on each the surface and within cells. By gaining access to numerous areas of the body, they need the potential to discover malady and deliver treatment in ways in which undreamt of previously.

References

1. https://www.cancer.gov/nano/cancer-nanotechnology/treatment

Citation

Citation: Yadav Ajay Kumar., et al. “Nanoparticles and Targeted Cancer Therapy". Acta Scientific Cancer Biology 5.10 (2021): 16-18.

Copyright

Copyright: © 2021 Yadav Ajay Kumar., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.